Atopic Dermatitis Clinical Trials in Portsmouth, New Hampshire

4 studies are recruiting for atopic dermatitis in Portsmouth, New Hampshire right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares

    This study will collect skin measurements from people with atopic dermatitis (AD) using the investigational Nevisense Go device. Participants aged 12 to 89 years with a history of AD flares will use the device at home for about 90 days. Participants will complete device measurements, electronic dia…

    Stage
    Not phased
    Ages
    12 to 89
    Site
    StracSkin, PLLC, Portsmouth, New Hampshire
    Locations
    10 in total
    Run by
    Castle Biosciences Incorporated

    See if you can join NCT07645820 on ClinicalTrials.gov

  2. Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

    This trial is designed to evaluate multiple compounds in participants with moderate to severe atopic dermatitis (AD).

    Stage
    Phase 2
    Ages
    18 to 100
    Site
    Novartis Investigative Site, Portsmouth, New Hampshire
    Locations
    105 in total
    Run by
    Novartis Pharmaceuticals

    See if you can join NCT06947993 on ClinicalTrials.gov

  3. This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment

    The objectives of this prospective non-interventional study are to characterize the existing unmet needs across the spectrum of atopic dermatitis (AD), enhance the understanding of the patient journey, and evaluate the safety and clinical outcomes of systemic AD treatments in a real-world setting. …

    Stage
    Not phased
    Ages
    12 and older
    Site
    Optima Research Portsmouth- Site Number : 8400032, Portsmouth, New Hampshire
    Locations
    79 in total
    Run by
    Sanofi

    See if you can join NCT07290803 on ClinicalTrials.gov

  4. Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

    The main aim of the study is to assess real-world effectiveness of nemolizumab in Atopic Dermatitis (AD) as measured by physician assessment and patient reported outcome (PRO) in clinical practice at Month 6.

    Stage
    Not phased
    Ages
    12 and older
    Site
    Galderma Investigational Site 7055, Portsmouth, New Hampshire
    Locations
    108 in total
    Run by
    Galderma R&D

    See if you can join NCT06988605 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.